2 Things Just Happened That Make Vertex Pharmaceuticals Stock a Screaming Buy
I've maintained for quite a while that Vertex Pharmaceuticals (NASDAQ: VRTX) is the best biotech stock on the market. My thinking was -- and is -- that Vertex's virtual monopoly in the cystic fibrosis (CF) market, combined with several shots on goal in treating other diseases, gave it a huge advantage.
But Vertex stock now looks more attractive than ever. In fact, I think the biotech stock is a screaming buy right now. And it's because of two enormously important things that happened over the last four days.
Image source: Getty Images.
Source Fool.com
